Trial Profile
Assessment of the phenotype of the type 2 diabetic responders to the first insulinisation using Lantus (insulin glargine) plus glucophage (metformin) combination after failure in OADs [oral antidiabetics] treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GALATEE
- Sponsors Sanofi
- 29 Apr 2008 New trial record.